Share on StockTwits

The Clorox (NYSE:CLX) was downgraded by stock analysts at BTIG Research from a “buy” rating to a “neutral” rating in a report issued on Friday, reports.

CLX has been the subject of a number of other recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of The Clorox in a research note on Friday, May 16th. They now have a $93.00 price target on the stock. Separately, analysts at B. Riley cut their price target on shares of The Clorox from $85.00 to $79.00 in a research note on Monday, May 12th. They now have a “neutral” rating on the stock. Finally, analysts at BMO Capital Markets cut their price target on shares of The Clorox from $83.00 to $4.00 in a research note on Tuesday, May 6th. Four investment analysts have rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $79.89.

The Clorox (NYSE:CLX) opened at 92.04 on Friday. The Clorox has a one year low of $80.20 and a one year high of $96.76. The stock has a 50-day moving average of $91.1 and a 200-day moving average of $89.07. The company has a market cap of $11.835 billion and a price-to-earnings ratio of 21.52.

The Clorox (NYSE:CLX) last released its earnings data on Thursday, May 1st. The company reported $1.05 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.08 by $0.03. The company had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter in the prior year, the company posted $1.00 earnings per share. The company’s quarterly revenue was down 1.9% on a year-over-year basis. Analysts expect that The Clorox will post $4.32 EPS for the current fiscal year.

The Clorox Company (NYSE:CLX) is a manufacturer and marketer of consumer and professional products.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.